Vaping cessation has emerged as a critical focus in public health, particularly among teens and young adults increasingly drawn to nicotine products.Recent findings from a study conducted by Mass General Brigham highlighted that participants who used varenicline—an FDA-approved medication originally designed for smoking cessation—were over three times more likely to successfully quit vaping compared to those who received only behavioral support.